Insider Holders & Insider Ownership - PLUS THERAPEUTICS INC. (PSTV)

List of insiders holdings for PLUS THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 Lim Kian Thiam
10% Owner		 2015-04-20 15:27:05 7,400,000
0		 7,400,000 Form 4
2 OLYMPUS CORP
10% Owner		 2014-09-16 06:01:15 3,973,043
0		 3,973,043 Form 13D
3 PostFinance AG
10% Owner		 2018-05-24 16:16:07 2,795,561
0		 2,795,561 Form 13G
4 Saad Mark E
Chief Financial Officer		 2014-04-15 16:03:45 1,228,430
0		 1,228,430 Form 4
5 SHIRAHAMA NORIO SEIJIRO
President - Asia Pacific		 2015-02-03 19:29:24 881,159
0		 881,159 Form 4
6 COX MARSHALL G
Director		 2007-02-28 17:34:31 480,000
0		 480,000 Form 4
7 HENRIKSEN RONALD D
Director		 2012-01-04 19:12:26 438,592
0		 438,592 Form 4
8 HEDRICK MARC H
Chief Executive Officer		 2025-02-20 17:30:05 400,489
0		 400,489 Form 4
9 REUTER BRUCE
SVP Sales, Market., Distr.		 2009-02-02 16:55:15 394,686
0		 394,686 Form 4
10 SCHULZKI SHARON
Chief Operating Officer		 2005-02-04 19:20:34 380,000
0		 380,000 Form 4
11 Swissquote Bank SA
10% Owner		 2018-08-28 11:11:40 376,723
0		 376,723 Form 13G
12 GALETTO CHARLES
Sr. Vice President Finance & A		 2006-01-26 16:56:35 280,000
0		 280,000 Form 4
13 Arm Douglas M
Sr. VP - Operations		 2009-05-04 20:33:40 185,000
0		 185,000 Form 4
14 SCARBROUGH ELIZABETH
Vice President Marketing & Dev		 2006-01-26 17:16:02 176,250
0		 176,250 Form 4
15 FRASER JOHN K
Vice President Research & Tech		 2005-02-04 16:46:59 166,250
0		 166,250 Form 4
16 SCOTT MATTHEW
Vice President Sales		 2004-06-04 17:46:43 165,000
0		 165,000 Form 4
17 Milstein Alexander M
VP - Clinical Development		 2009-02-02 16:57:24 155,000
0		 155,000 Form 4
18 CALHOUN CHRISTOPHER J
Chief Executive Officer		 2014-01-14 18:11:01 118,125
36,850		 154,975 Form 4
19 Townsend John
Controller		 2015-02-03 19:30:39 139,850
0		 139,850 Form 4
20 Thompson Tommy G
Director		 2016-01-04 17:55:54 136,950
0		 136,950 Form 4
21 Ransom John T
VP Research Regn. Cell Techn.		 2007-02-28 18:00:20 105,000
0		 105,000 Form 4
22 Dean Lloyd H
Director		 2014-05-20 12:17:05 51,059
40,000		 91,059 Form 4
23 Sims Andrew John Hugh MacIntyre
Chief Financial Officer		 2025-02-20 17:30:09 60,020
0		 60,020 Form 4
24 HOLMES E CARMACK
Director		 2014-05-20 12:09:12 19,517
37,401		 56,918 Form 4
25 MARTELL RON
Director		 2017-01-27 17:46:09 50,000
0		 50,000 Form 4
26 LAPOINTE ANTHONY GREGG
Director		 2017-05-24 16:35:45 50,000
0		 50,000 Form 4
27 Jona Ruud J.P.
Director		 2014-06-12 16:25:53 42,000
0		 42,000 Form 4
28 Hawkins Richard J
Director		 2025-02-20 17:30:11 40,122
0		 40,122 Form 4
29 Petersen Greg
Director		 2025-02-20 17:30:03 40,122
0		 40,122 Form 4
30 van Es-Johansson An
Director		 2025-02-20 17:30:06 40,122
0		 40,122 Form 4
31 Lenk Robert P
Director		 2025-02-20 17:30:09 40,122
0		 40,122 Form 4
32 Clowes Howard
Director		 2025-02-20 17:30:10 40,122
0		 40,122 Form 4
33 Marino Mark
Chief Medical Officer		 2017-03-17 17:10:48 31,100
0		 31,100 Form 4/A
34 HAYDEN JEREMY B.
General Counsel & VP of BD		 2017-03-17 17:08:19 31,100
0		 31,100 Form 4/A
35 HAWRAN PAUL W
Director		 2017-01-27 17:48:43 25,000
0		 25,000 Form 4
36 LaFrance Norman D.
Chief Medical Officer		 2024-02-26 18:26:31 24,073
0		 24,073 Form 4
37 RICKEY DAVID
Director		 2017-11-29 17:40:07 10,806
0		 10,806 Form 4
38 KESTEN STEVEN
Exec VP and Chief MO		 2016-06-15 18:56:21 3,581
400		 3,981 Form 4
39 LYONS GARY A
Director		 2018-02-09 16:54:03 1,801
0		 1,801 Form 4
40 HARRIS JOHN DAVID
VP and GM Cell Therapy		 2017-11-29 17:34:41 1,801
0		 1,801 Form 4
41 Naughton Gail K
Director		 2017-11-29 17:39:06 1,801
0		 1,801 Form 4
42 Girao Tiago
VP & Chief Financial Officer		 2018-07-27 16:31:45 1,051
0		 1,051 Form 4